Electroconvulsive therapy in the era of modern psychopharmacology

Research output: Contribution to journalReview article

58 Citations (Scopus)

Abstract

Fifty years of advances in the pharmacotherapy of major depression (MDE), mania, schizophrenia, and other severe and persistent psychiatric disorders have neither made ECT obsolete nor unnecessary. However, advances in pharmacotherapy have radically changed the practice of ECT. ECT is rarely a first-line treatment of mental disorder, unless the clinical situation is desperate. Otherwise, ECT is most often offered to persons who have failed to respond to pharmacotherapy, thus defining a relatively treatment-refractory population for ECT. The physician who refers patients for ECT, as well as the ECT provider, must be able to judge at what point a patient is deemed 'medication resistant', implying expertise in pharmacotherapy for both the referring physician and the ECT provider. Authoritative sources from 20 years ago quoted antidepressant response rates ≥ 90% for ECT, but the antidepressant response rate in medication-resistant MDE may be only 60%. Improvements in the safety of ECT have resulted in the referral of large numbers of older persons for ECT. High relapse rates after ECT are perhaps the biggest problem presently facing patients and providers. High relapse rates are not surprising given that (i) most patients are medication resistant, and (ii) ECT is usually withdrawn at the moment it becomes effective. Although continuation/maintenance ECT is an option in preventing relapse, it may not be a practical solution for persons still in their productive years, and it is resource-intensive. Still, continuation/maintenance ECT is the only method to prevent relapse and recurrence of severe psychiatric disorder for some persons.

Original languageEnglish (US)
Pages (from-to)315-324
Number of pages10
JournalInternational Journal of Neuropsychopharmacology
Volume4
Issue number3
DOIs
StatePublished - Dec 1 2001
Externally publishedYes

Fingerprint

Psychopharmacology
Electroconvulsive Therapy
Recurrence
Drug Therapy
Antidepressive Agents
Psychiatry
Maintenance
Depression
Physicians
Bipolar Disorder
Mental Disorders
Schizophrenia
Referral and Consultation
Safety
Therapeutics
Population

Keywords

  • Catatonia
  • Electroconvulsive therapy
  • Major depression
  • Neuroleptic malignant syndrome
  • Parkinson's disease
  • Relapse
  • Treatment resistance

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Electroconvulsive therapy in the era of modern psychopharmacology. / McCall, William Vaughn.

In: International Journal of Neuropsychopharmacology, Vol. 4, No. 3, 01.12.2001, p. 315-324.

Research output: Contribution to journalReview article

@article{c377d3c065384cc2b0e8c7c6b9356e71,
title = "Electroconvulsive therapy in the era of modern psychopharmacology",
abstract = "Fifty years of advances in the pharmacotherapy of major depression (MDE), mania, schizophrenia, and other severe and persistent psychiatric disorders have neither made ECT obsolete nor unnecessary. However, advances in pharmacotherapy have radically changed the practice of ECT. ECT is rarely a first-line treatment of mental disorder, unless the clinical situation is desperate. Otherwise, ECT is most often offered to persons who have failed to respond to pharmacotherapy, thus defining a relatively treatment-refractory population for ECT. The physician who refers patients for ECT, as well as the ECT provider, must be able to judge at what point a patient is deemed 'medication resistant', implying expertise in pharmacotherapy for both the referring physician and the ECT provider. Authoritative sources from 20 years ago quoted antidepressant response rates ≥ 90{\%} for ECT, but the antidepressant response rate in medication-resistant MDE may be only 60{\%}. Improvements in the safety of ECT have resulted in the referral of large numbers of older persons for ECT. High relapse rates after ECT are perhaps the biggest problem presently facing patients and providers. High relapse rates are not surprising given that (i) most patients are medication resistant, and (ii) ECT is usually withdrawn at the moment it becomes effective. Although continuation/maintenance ECT is an option in preventing relapse, it may not be a practical solution for persons still in their productive years, and it is resource-intensive. Still, continuation/maintenance ECT is the only method to prevent relapse and recurrence of severe psychiatric disorder for some persons.",
keywords = "Catatonia, Electroconvulsive therapy, Major depression, Neuroleptic malignant syndrome, Parkinson's disease, Relapse, Treatment resistance",
author = "McCall, {William Vaughn}",
year = "2001",
month = "12",
day = "1",
doi = "10.1017/S1461145701002437",
language = "English (US)",
volume = "4",
pages = "315--324",
journal = "International Journal of Neuropsychopharmacology",
issn = "1461-1457",
publisher = "Cambridge University Press",
number = "3",

}

TY - JOUR

T1 - Electroconvulsive therapy in the era of modern psychopharmacology

AU - McCall, William Vaughn

PY - 2001/12/1

Y1 - 2001/12/1

N2 - Fifty years of advances in the pharmacotherapy of major depression (MDE), mania, schizophrenia, and other severe and persistent psychiatric disorders have neither made ECT obsolete nor unnecessary. However, advances in pharmacotherapy have radically changed the practice of ECT. ECT is rarely a first-line treatment of mental disorder, unless the clinical situation is desperate. Otherwise, ECT is most often offered to persons who have failed to respond to pharmacotherapy, thus defining a relatively treatment-refractory population for ECT. The physician who refers patients for ECT, as well as the ECT provider, must be able to judge at what point a patient is deemed 'medication resistant', implying expertise in pharmacotherapy for both the referring physician and the ECT provider. Authoritative sources from 20 years ago quoted antidepressant response rates ≥ 90% for ECT, but the antidepressant response rate in medication-resistant MDE may be only 60%. Improvements in the safety of ECT have resulted in the referral of large numbers of older persons for ECT. High relapse rates after ECT are perhaps the biggest problem presently facing patients and providers. High relapse rates are not surprising given that (i) most patients are medication resistant, and (ii) ECT is usually withdrawn at the moment it becomes effective. Although continuation/maintenance ECT is an option in preventing relapse, it may not be a practical solution for persons still in their productive years, and it is resource-intensive. Still, continuation/maintenance ECT is the only method to prevent relapse and recurrence of severe psychiatric disorder for some persons.

AB - Fifty years of advances in the pharmacotherapy of major depression (MDE), mania, schizophrenia, and other severe and persistent psychiatric disorders have neither made ECT obsolete nor unnecessary. However, advances in pharmacotherapy have radically changed the practice of ECT. ECT is rarely a first-line treatment of mental disorder, unless the clinical situation is desperate. Otherwise, ECT is most often offered to persons who have failed to respond to pharmacotherapy, thus defining a relatively treatment-refractory population for ECT. The physician who refers patients for ECT, as well as the ECT provider, must be able to judge at what point a patient is deemed 'medication resistant', implying expertise in pharmacotherapy for both the referring physician and the ECT provider. Authoritative sources from 20 years ago quoted antidepressant response rates ≥ 90% for ECT, but the antidepressant response rate in medication-resistant MDE may be only 60%. Improvements in the safety of ECT have resulted in the referral of large numbers of older persons for ECT. High relapse rates after ECT are perhaps the biggest problem presently facing patients and providers. High relapse rates are not surprising given that (i) most patients are medication resistant, and (ii) ECT is usually withdrawn at the moment it becomes effective. Although continuation/maintenance ECT is an option in preventing relapse, it may not be a practical solution for persons still in their productive years, and it is resource-intensive. Still, continuation/maintenance ECT is the only method to prevent relapse and recurrence of severe psychiatric disorder for some persons.

KW - Catatonia

KW - Electroconvulsive therapy

KW - Major depression

KW - Neuroleptic malignant syndrome

KW - Parkinson's disease

KW - Relapse

KW - Treatment resistance

UR - http://www.scopus.com/inward/record.url?scp=0035700945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035700945&partnerID=8YFLogxK

U2 - 10.1017/S1461145701002437

DO - 10.1017/S1461145701002437

M3 - Review article

C2 - 11602037

AN - SCOPUS:0035700945

VL - 4

SP - 315

EP - 324

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

SN - 1461-1457

IS - 3

ER -